This inventor holds 1 USPTO granted patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Wendy Jean Morrison: Innovator in Multiple Sclerosis Research
Introduction
Wendy Jean Morrison is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of medical research, particularly in the area of multiple sclerosis. Her innovative work focuses on methods that can aid in the diagnosis and monitoring of this complex disease.
Latest Patents
Wendy holds a patent for her invention titled "Methods of measuring urinary myelin basic protein-like material." This invention provides a method for determining the status of a multiple sclerosis patient, specifically predicting the transition from a relapsing-remitting phase to a progressive phase. The method involves measuring the levels of urinary myelin basic protein-like material in the patient. Additionally, it offers a way to assess the amount of lesions and total lesion area in multiple sclerosis patients. Furthermore, her invention includes a method for monitoring myelination in developing children by measuring the levels of myelin basic protein-like material in their urine. Wendy has 1 patent to her name.
Career Highlights
Wendy is associated with the UAB Research Foundation, which is part of the University of Alabama at Birmingham. Her work at this institution has allowed her to collaborate with other researchers and contribute to advancements in medical science.
Collaborations
Wendy has worked alongside notable colleagues such as John Nicholas Whitaker and Robert David Kachelhofer. Their collaborative efforts have furthered research in the field of multiple sclerosis and related areas.
Conclusion
Wendy Jean Morrison's innovative contributions to multiple sclerosis research highlight her dedication to improving patient outcomes. Her patented methods represent a significant advancement in the understanding and monitoring of this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
